BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22019564)

  • 1. Phosphodiesterases and regulation of female reproductive function.
    Conti M
    Curr Opin Pharmacol; 2011 Dec; 11(6):665-9. PubMed ID: 22019564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.
    Manganiello V
    Curr Opin Pharmacol; 2011 Dec; 11(6):646-8. PubMed ID: 22079477
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants.
    Wang P; Wu P; Egan RW; Billah MM
    Gene; 2003 Sep; 314():15-27. PubMed ID: 14527714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotide phosphodiesterase activities of the embryonic chick ovary.
    Teng CT; Buchler B; Teng CS
    Gen Comp Endocrinol; 1981 Aug; 44(4):409-17. PubMed ID: 6167486
    [No Abstract]   [Full Text] [Related]  

  • 5. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.
    Manganiello VC; Murata T; Taira M; Belfrage P; Degerman E
    Arch Biochem Biophys; 1995 Sep; 322(1):1-13. PubMed ID: 7574662
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 7. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE inhibitors: a new approach to treat metabolic syndrome?
    Lugnier C
    Curr Opin Pharmacol; 2011 Dec; 11(6):698-706. PubMed ID: 22018840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.
    Levy I; Horvath A; Azevedo M; de Alexandre RB; Stratakis CA
    Curr Opin Pharmacol; 2011 Dec; 11(6):689-97. PubMed ID: 22047791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.
    Tsai LC; Beavo JA
    Curr Opin Pharmacol; 2011 Dec; 11(6):670-5. PubMed ID: 21962440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drosophila cyclic nucleotide phosphodiesterases.
    Davis RL; Kauvar LM
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterases in neurodegenerative disorders.
    Bollen E; Prickaerts J
    IUBMB Life; 2012 Dec; 64(12):965-70. PubMed ID: 23129425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterase assay technology.
    MacKenzie SJ; Hastings SF; Wells C
    Curr Protoc Pharmacol; 2010 Jun; Chapter 3():Unit 3.12. PubMed ID: 22294369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase expression in human epithelial cells.
    Wright LC; Seybold J; Robichaud A; Adcock IM; Barnes PJ
    Am J Physiol; 1998 Oct; 275(4):L694-700. PubMed ID: 9755101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of cyclic nucleotide phosphodiesterases in Drosophila melanogaster.
    Kiger JA; Davis RL; Salz H; Fletcher T; Bowling M
    Adv Cyclic Nucleotide Res; 1981; 14():273-88. PubMed ID: 6269382
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III cyclic nucleotide phosphodiesterases and insulin action.
    Manganiello VC; Degerman E; Taira M; Kono T; Belfrage P
    Curr Top Cell Regul; 1996; 34():63-100. PubMed ID: 8646851
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages.
    Witwicka H; Kobiałka M; Siednienko J; Mitkiewicz M; Gorczyca WA
    Biochim Biophys Acta; 2007 Feb; 1773(2):209-18. PubMed ID: 17141339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cyclic nucleotide phosphodiesterases in resumption of meiosis.
    Conti M; Andersen CB; Richard FJ; Shitsukawa K; Tsafriri A
    Mol Cell Endocrinol; 1998 Oct; 145(1-2):9-14. PubMed ID: 9922093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.